Bacterin pre-announces strong Q1

|By:, SA News Editor

Bacterin (BONE) expects Q1 revenue of $8.7M-$8.9M, +7% Q/Q and +2% Y/Y, and above an $8.5M consensus.

Core recurring Biologics revenue (excludes stocking orders) are expected to total $8.55M-$8.65M, up 7% Q/Q and 20% Y/Y.

Full Q1 results are due on May 6.